Cardinal Health (CAH) Q4 FY25 earnings call

Cardinal Health closed FY25 with strong momentum, achieving double-digit profit growth across all segments and exceeding free cash flow targets. The company is strategically expanding its Specialty Alliances platform through acquisitions like Solaris Health, while also driving operational efficiencies in its core businesses. Management is confident in its resilient business model and ability to deliver continued growth in FY26, despite some minor Q4 Pharma headwinds and anticipated Q2 FY26 tariff impacts in GMPD.